CXCL12 and non-small cell lung carcinoma: The expression of chemokine CXCL12 and its receptor, CXCR4, is significantly higher in NSCLC samples of patients with brain metastases [32], which allow for the differentiation between NSCLC patients without and with brain metastases, with good diagnostic accuracy and adequate predictive power [32].